Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Biomarkers of disease activity in multiple sclerosis.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
The cell biology of CNS myelination.
Flupirtine in pain management: pharmacological properties and clinical use.
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.

Pages